Cargando…

Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors

BACKGROUND: The periacetabular area is one of the primary sites of metastatic tumors, which often present as osteolytic bone destruction. Bone destruction in the acetabulum caused by metastatic tumors will cause hip pain and joint dysfunction. It results in decreased quality of life for patients. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinlei, Yang, Zuozhang, Wang, Jiaping, Wang, Jinde, Liu, Pengjie, Sun, Hongpu, Li, Kun, Yang, Yunshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546855/
https://www.ncbi.nlm.nih.gov/pubmed/23164341
http://dx.doi.org/10.1186/1477-7819-10-250
_version_ 1782256120858935296
author Zhang, Jinlei
Yang, Zuozhang
Wang, Jiaping
Wang, Jinde
Liu, Pengjie
Sun, Hongpu
Li, Kun
Yang, Yunshan
author_facet Zhang, Jinlei
Yang, Zuozhang
Wang, Jiaping
Wang, Jinde
Liu, Pengjie
Sun, Hongpu
Li, Kun
Yang, Yunshan
author_sort Zhang, Jinlei
collection PubMed
description BACKGROUND: The periacetabular area is one of the primary sites of metastatic tumors, which often present as osteolytic bone destruction. Bone destruction in the acetabulum caused by metastatic tumors will cause hip pain and joint dysfunction. It results in decreased quality of life for patients. The aim of our study was to explore the clinical effect of metastatic periacetabular tumors treated with percutaneous cementoplasty and interstitial implantation of (125)I seeds. METHODS: A retrospective analysis was performed on 24 patients with metastatic periacetabular tumors who underwent combined therapy of percutaneous acetabuloplasty and interstitial implantation of (125)I seeds between February 2003 and June 2011. There were 13 males and 11 females aged 19–80 years with a mean age of 57.3. The primary tumor site was the lung in eight cases, the breast in six, the prostate cancer in eight, and the liver in two. The amount of implanted (125)I seeds was 12–20 seeds/person, with a mean of 16.5 seeds/person, and the matching peripheral dosage (MPD) was 80~100Gy. Routine postoperative chemotherapy and other combined treatments were applied to patients after the surgical operation. Changes in the Karnofsky Score(KPS), Harris Hip Score(Harris), and Visual Analog Scale(VAS) were observed during the follow-up period. RESULTS: The 24 patients’ operations were all successful. No major complications occurred. Complete pain relief was achieved in 58% (14 of 24) of patients, and pain reduction was achieved in the 42% remaining (10) patients. The mean duration of pain relief was 8.3 months. Pain recurred in one patient 3 months after surgery. Six patients had died and 18 patients were alive at the time of the 1-year follow-up. Comparing the KPS, Harris and VAS scores pre- and postoperativelyat 1, 6, and 12 months, the combined therapy method was significantly effective in metastatic periacetabular tumor patients (P<0.05). CONCLUSIONS: Percutaneous cementoplasty with interstitial implantation of (125)I seeds is an effective treatment method for metastatic periacetabular tumor patients, providing tumor resistance, pain relief, increased bone stability, and improved quality of life for patients.
format Online
Article
Text
id pubmed-3546855
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35468552013-01-17 Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors Zhang, Jinlei Yang, Zuozhang Wang, Jiaping Wang, Jinde Liu, Pengjie Sun, Hongpu Li, Kun Yang, Yunshan World J Surg Oncol Research BACKGROUND: The periacetabular area is one of the primary sites of metastatic tumors, which often present as osteolytic bone destruction. Bone destruction in the acetabulum caused by metastatic tumors will cause hip pain and joint dysfunction. It results in decreased quality of life for patients. The aim of our study was to explore the clinical effect of metastatic periacetabular tumors treated with percutaneous cementoplasty and interstitial implantation of (125)I seeds. METHODS: A retrospective analysis was performed on 24 patients with metastatic periacetabular tumors who underwent combined therapy of percutaneous acetabuloplasty and interstitial implantation of (125)I seeds between February 2003 and June 2011. There were 13 males and 11 females aged 19–80 years with a mean age of 57.3. The primary tumor site was the lung in eight cases, the breast in six, the prostate cancer in eight, and the liver in two. The amount of implanted (125)I seeds was 12–20 seeds/person, with a mean of 16.5 seeds/person, and the matching peripheral dosage (MPD) was 80~100Gy. Routine postoperative chemotherapy and other combined treatments were applied to patients after the surgical operation. Changes in the Karnofsky Score(KPS), Harris Hip Score(Harris), and Visual Analog Scale(VAS) were observed during the follow-up period. RESULTS: The 24 patients’ operations were all successful. No major complications occurred. Complete pain relief was achieved in 58% (14 of 24) of patients, and pain reduction was achieved in the 42% remaining (10) patients. The mean duration of pain relief was 8.3 months. Pain recurred in one patient 3 months after surgery. Six patients had died and 18 patients were alive at the time of the 1-year follow-up. Comparing the KPS, Harris and VAS scores pre- and postoperativelyat 1, 6, and 12 months, the combined therapy method was significantly effective in metastatic periacetabular tumor patients (P<0.05). CONCLUSIONS: Percutaneous cementoplasty with interstitial implantation of (125)I seeds is an effective treatment method for metastatic periacetabular tumor patients, providing tumor resistance, pain relief, increased bone stability, and improved quality of life for patients. BioMed Central 2012-11-20 /pmc/articles/PMC3546855/ /pubmed/23164341 http://dx.doi.org/10.1186/1477-7819-10-250 Text en Copyright ©2012 Zhang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhang, Jinlei
Yang, Zuozhang
Wang, Jiaping
Wang, Jinde
Liu, Pengjie
Sun, Hongpu
Li, Kun
Yang, Yunshan
Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title_full Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title_fullStr Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title_full_unstemmed Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title_short Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors
title_sort study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)i seeds for patients with metastatic periacetabular tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546855/
https://www.ncbi.nlm.nih.gov/pubmed/23164341
http://dx.doi.org/10.1186/1477-7819-10-250
work_keys_str_mv AT zhangjinlei studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT yangzuozhang studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT wangjiaping studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT wangjinde studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT liupengjie studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT sunhongpu studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT likun studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors
AT yangyunshan studyoftreatmentusingpercutaneousacetabuloplastyandinterstitialimplantationof125iseedsforpatientswithmetastaticperiacetabulartumors